未登录

S

Simon Vyse

The Institute of Cancer Research

H指数:16

被引数:1,617

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer

非小细胞肺癌中罕见的表皮生长因子受体 (EGFR) 突变

SEMINARS IN CANCER BIOLOGY

IF15.7

2020-04-01369

OAAI

Targeting EGFR exon 20 insertions in non-small cell lung cancer by exploiting a dependency on parallel SRC signalling

ANNALS OF ONCOLOGY

IF65.4

2019-11-010

OAAI

Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer

Signal Transduction and Targeted Therapy

IF52.7

2019-03-080

OAAI

Primary Cilia Mediate Diverse Kinase Inhibitor Resistance Mechanisms in Cancer

IF6.9

2018-06-0186

OAAI

De novo mutations implicate novel genes in systemic lupus erythematosus

HUMAN MOLECULAR GENETICS

IF3.2

2017-11-2142

OAAI

Exploiting receptor tyrosine kinase co-activation for cancer therapy

DRUG DISCOVERY TODAY

IF7.5

2017-01-0128

OAAI

Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model

JOURNAL OF PATHOLOGY

IF5.2

2016-10-1943

OAAI

Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors

IF6.9

2016-10-0152

OAAI

SLE ASSOCIATED UBE2L3 HAPLOTYPE MODULATES PLASMA CELL DIFFERENTIATION VIA GENOTYPIC REGULATION OF NF-κB

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2015-03-010

PREAI

Effect of UBE2L3 genotype on regulation of the linear ubiquitin chain assembly complex in systemic lupus erythematosus

IF88.5

2015-02-0116

OAAI

UBE2L3 Polymorphism Amplifies NF-κB Activation and Promotes Plasma Cell Development, Linking Linear Ubiquitination to Multiple Autoimmune Diseases

AMERICAN JOURNAL OF HUMAN GENETICS

IF8.1

2015-02-0184

OAAI